Multifaceted role of matrix metalloproteinases (MMPs)

被引：153

作者：

Singh, Divya ^{[1
]}

Srivastava, Sanjeev K. ^{[2
]}

Chaudhuri, Tapas K. ^{[2
]}

Upadhyay, Ghanshyam ^{[1
]}

机构：

[1] CUNY City Coll, Dept Biol, Marshak Bldg,160 Convent Ave, New York, NY 10031 USA

[2] Univ North Bengal, Dept Zool, Cellular Immunol Lab, Siliguri 734013, India

来源：

FRONTIERS IN MOLECULAR BIOSCIENCES | 2015年 / 2卷

关键词：

MMP2; MMP9; neurodegenerative disorders; Japanese encephalitis; glaucoma; JAPANESE ENCEPHALITIS-VIRUS; DIFFERENT BRAIN-REGIONS; CENTRAL-NERVOUS-SYSTEM; TISSUE INHIBITORS; AMYLOID-BETA; INTRAOCULAR-PRESSURE; MOLECULAR-BIOLOGY; GELATINASE-B; MOUSE-BRAIN; STEM-CELLS;

D O I：

10.3389/fmolb.2015.00019

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Matrix metalloproteinases (MMPs), a large family of calcium-dependent zinc-containing endopeptidases, are involved in the tissue remodeling and degradation of the extracellular matrix. MMPs are widely distributed in the brain and regulate various processes including microglial activation, inflammation, dopaminergic apoptosis, blood-brain barrier disruption, and modulation of alpha-synuclein pathology. High expression of MMPs is well documented in various neurological disorders including Parkinson's disease (PD), Alzheimer's disease (AD), Japanese encephalitis (JE), and Glaucoma. Although potentially critical, the role of MMPs in neuronal disorders is under-investigated. The present review summarizes the role of MMPs in neurodegeneration with a particular emphasis on PD, AD, JE, and Glaucoma.

引用

页数：5

共 56 条

[31] Increased plasma levels of matrix metalloproteinase-9 in patients with Alzheimer's disease [J].

Lorenzl, S ;

Albers, DS ;

Relkin, N ;

Ngyuen, T ;

Hilgenberg, SL ;

Chirichigno, J ;

Cudkowicz, ME ;

Beal, MF .

NEUROCHEMISTRY INTERNATIONAL, 2003, 43 (03) :191-196

[32] Expression of MMP-2, MMP-9, and MMP-1 and their endogenous counterregulators TIMP-1 and TIMP-2 in postmortem brain tissue of Parkinson's disease [J].

Lorenzl, S ;

Albers, DS ;

Narr, S ;

Chirichigno, J ;

Beal, MF .

EXPERIMENTAL NEUROLOGY, 2002, 178 (01) :13-20

[33] Aβ-degrading enzymes in Alzheimer's disease [J].

Miners, James Scott ;

Baig, Shabnam ;

Palmer, Jennifer ;

Palmer, Laura E. ;

Kehoe, Patrick G. ;

Love, Seth .

BRAIN PATHOLOGY, 2008, 18 (02) :240-252

[34] A study of motor activity and catecholamine levels in different brain regions following Japanese encephalitis virus infection in rats [J].

Misra, Usha Kant ;

Kumar, Sandeep ;

Kalita, Jayantee ;

Ahmad, Ausaf ;

Khanna, Vinay Kumar ;

Khan, Mohammad Yahiya ;

Palit, Gautam .

BRAIN RESEARCH, 2009, 1292 :136-147

[35]

Pagenstecher A, 1998, AM J PATHOL, V152, P729

[36] Neuronal death in glaucoma [J].

Quigley, HA .

PROGRESS IN RETINAL AND EYE RESEARCH, 1999, 18 (01) :39-57

[37] Matrix metalloproteinases and their multiple roles in neurodegenerative diseases [J].

Rosenberg, Gary A. .

LANCET NEUROLOGY, 2009, 8 (02) :205-216

[38] β1 Integrin-Focal Adhesion Kinase (FAK) Signaling Modulates Retinal Ganglion Cell (RGC) Survival [J].

Santos, Andrea Rachelle C. ;

Corredor, Raul G. ;

Obeso, Betty Albo ;

Trakhtenberg, Ephraim F. ;

Wang, Ying ;

Ponmattam, Jamie ;

Dvoriantchikova, Galina ;

Ivanov, Dmitry ;

Shestopalov, Valery I. ;

Goldberg, Jeffrey L. ;

Fini, Mary Elizabeth ;

Bajenaru, Michaela Livia .

PLOS ONE, 2012, 7 (10)

[39]

Selkoe Dennis J, 2008, Handb Clin Neurol, V89, P245, DOI 10.1016/S0072-9752(07)01223-7

[40] Matrix metalloproteinase-3 is activated by HtrA2/Omi in dopaminergic cells: Relevance to Parkinson's disease [J].

Shin, Eun Jung ;

Kim, Eun-Mee ;

Lee, Ji Ae ;

Rhim, Hyangshuk ;

Hwang, Onyou .

NEUROCHEMISTRY INTERNATIONAL, 2012, 60 (03) :249-256

← 1 2 3 4 5 6 →